Gerhard Burbach

Gerhard F.
Burbach is currently Chairman at Procyrion, Inc. since 2016, Chairman at International Life Sciences LLC, Chairman at Rampart LLC, Director at Vascular Dynamics, Inc., Independent Director at BWX Technologies, Inc. since 2018, Director at Artelon, Inc., Director at BRIUS Technologies, Inc., and Director at Sight Sciences, Inc. starting in 2025.
Former roles include President, Chief Executive Officer & Director at Thoratec Corp.
from 2006 to 2014; President & Chief Executive Officer & Director at Star Operating Cos., Inc. from 2005 to 2006; Chief Executive Officer at Phillips Electronics, Inc. from 2001 to 2003; President & Chief Executive Officer at Bacchus Vascular, Inc. in 2005; Chief Executive Officer at Philips Nuclear Medicine, Inc. from 2001 to 2003; Chairman at Autonomic Technologies, Inc. from 2016 to 2019; Independent Director at Standard BioTools, Inc. from 2013 to 2023; President & GM-Nuclear Medicine Division at ADAC Laboratories, Inc.; and Senior Manager-Engagement at McKinsey & Co., Inc. Education includes an undergraduate degree from Stanford University in 1984 and an MBA from Harvard Business School in 1990.